Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
20.17
+0.30 (1.51%)
At close: Apr 24, 2025, 4:00 PM
19.88
-0.29 (-1.44%)
Pre-market: Apr 25, 2025, 7:03 AM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.96 billion as of April 25, 2025. Its market cap has decreased by -13.51% in one year.
Market Cap
1.96B
Enterprise Value
1.27B
1-Year Change
-13.51%
Ranking
Category
Stock Price
$20.17
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.96B, an increase of 498.16%. That is a compound annual growth rate of 40.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 1.93B | -2.09% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 765.09B |
| UnitedHealth Group | 387.89B |
| Johnson & Johnson | 372.44B |
| AbbVie | 317.23B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.54B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |